GlassScriptPhysician profile
Vatsal Ladia
NPI 1831476688
$38,632.82
in general payments reported to CMS, 2019-2025
33 companies · $7,519 in 2025
The $7,519 reported for 2025 was more than what 75% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $5,708 · 2021: $1,711 · 2022: $3,923 · 2023: $2,244 · 2024: $667 · 2025: $7,519.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,489 · Travel and Lodging: $2,641 · Consulting Fee: $2,300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,489.15 |
| Travel and Lodging | $2,641.13 |
| Consulting Fee | $2,300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $17,027.80 | 2019-2020 | |
| Boston Scientific Corporation | $7,690.52 | 2019-2025 | Farapulse, Watchman Access System, Watchman Flx |
| Medtronic, INC. | $4,484.62 | 2021-2025 | Affera Mapping System, Corevalve Evolut R |
| Biosense Webster, INC. | $3,229.91 | 2019-2025 | Carto 3 |
| Abbott Laboratories | $2,377.84 | 2019-2025 | Ensite, Cardiomems, Gallant |
| Atricure, INC. | $455.55 | 2023-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System, Epi-Ease Epicardial Access System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $399.24 | 2019-2024 | Lifevest |
| Medical Device Business Services, INC. | $357.62 | 2019 | |
| Impulse Dynamics (USA) INC. | $293.75 | 2022-2025 | Optimizer, Optimizer |
| Astrazeneca Pharmaceuticals LP | $293.71 | 2021-2025 | Farxiga, Wainua |
| Novartis Pharmaceuticals Corporation | $250.68 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $244.65 | 2021-2024 | Jardiance |
| Merck Sharp & Dohme LLC | $239.31 | 2022-2024 | Verquvo |
| Philips North America LLC | $235.94 | 2022-2024 | (5091) Amb Mon & Diag Und |
| Janssen Pharmaceuticals, INC | $176.82 | 2023-2024 | Xarelto |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vital Connect, INC | $141.92 | 2023 | Vitalpatch Rtm |
| Abiomed | $122.81 | 2023-2024 | Impella |
| E.R. Squibb & Sons, L.L.C. | $90.13 | 2021-2023 | Camzyos |
| Alnylam Pharmaceuticals INC. | $72.12 | 2022-2025 | Amvuttra, Onpattro |
| Edwards Lifesciences Corporation | $61.22 | 2023-2024 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Biotronik INC. | $56.60 | 2022 | |
| Amgen INC. | $56.31 | 2020-2023 | Repatha |
| Novo Nordisk INC | $44.38 | 2024 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $43.91 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $39.87 | 2024 | |
| Daiichi Sankyo INC. | $24.10 | 2022 | |
| Chiesi USA, INC. | $19.62 | 2020 | |
| Veryan Medical Incorporated | $19.18 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $19.05 | 2023 | Arcalyst |
| Glaxosmithkline, LLC. | $18.38 | 2023 | Shingrix |
| Sanofi-Aventis U.S. LLC | $16.46 | 2022 | |
| Amarin Pharma, INC. | $14.82 | 2021 | |
| Pfizer INC. | $13.98 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vatsal Ladia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.